Left untreated, depression in the perinatal period can have serious repercussions for both mother and offspring.
A recent study examined maternal drug-related deaths and suicide in California and reveals opportunities for identifying at-risk new mothers.
Although the development of a PPD medication is commendable, Dr. Yonkers also notes there are several hurdles which need to be addressed.
In the United States, the Edinburgh Postnatal Depression Scale (EPDS) is the validated screening tool for postpartum depression most commonly used in current clinical practice.
Ob/gyns, support staff, and patients all need to be educated about the needs of the mother/child dyad during the “fourth trimester.”
An analog of an endogenous human hormone has been approved as treatment, but it comes with a steep price tag.
Referral for counseling is key for women at risk.
Internet addiction often is linked with depression but a new study suggests that there is a way to use the technology to help encourage teens with postpartum depression to get treatment.